ENSAYOPARALADETERMINACIÓNCUANTITATIVA DE ALIPOPROTEÍNAA-I - COFEPRIS Registration 1669C2021 SSA
Access comprehensive regulatory information for ENSAYOPARALADETERMINACIÓNCUANTITATIVA DE ALIPOPROTEÍNAA-I (ENSAYOPARALAQUANTITATIVE DETERMINATION OF ALIPOPROTEIN-I) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1669C2021 SSA and manufactured by ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on October 21, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ARCHITECT APOLIPOPROTEIN A1SE UTILIZA PARA LA DETERMINACIÓNCUANTITATIVADEAPOLIPOPROTEÍNA A-IENSUEROOPLASMAHUMANOSENARCHITECTCSYSTEMS. AGENTE DE DIAGNÓSTICO PARAUSO IN VITRO. PARA USO EXCLUSIVO DELABORATORIOS CLÍNICOS O DE GABINETE.
THE ARCHITECT APOLIPOPROTEIN A1 ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF APOLIPOPROTEIN A-IENSERUM HUMAN PLASMA IN ARCHITECTCSYSTEMS. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR EXCLUSIVE USE OF CLINICAL OR CABINET LABORATORIES.